Inflammatory myofibroblastic tumour

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Kinase inhibitor 1 substance
Phase I/II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I/II

1 trial
  • Prinses Maxima Centrum voor Kinderoncologie B.V. Academic
    BRIGATINIB
    2024-513412-10-00 12 countries 2022 n=54
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Prinses Maxima Centrum voor Kinderoncologie B.V. Academic 1 Phase I/II 1
New trials by year
2022
1
← All indication landscapes